Compare SLGL & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLGL | NMT |
|---|---|---|
| Founded | 1997 | 1993 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 107.8M |
| IPO Year | 2018 | N/A |
| Metric | SLGL | NMT |
|---|---|---|
| Price | $42.02 | $11.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 15.1K | ★ 19.1K |
| Earning Date | 11-20-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,970,000.00 | N/A |
| Revenue This Year | $121.82 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 62.04 | N/A |
| 52 Week Low | $4.02 | $9.05 |
| 52 Week High | $52.26 | $10.93 |
| Indicator | SLGL | NMT |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 42.04 |
| Support Level | $39.26 | $11.45 |
| Resistance Level | $44.04 | $11.65 |
| Average True Range (ATR) | 3.07 | 0.08 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 66.20 | 15.00 |
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.